Aprecia Pharmaceuticals' Series D Round

Aprecia Pharmaceuticals raised a round of funding on January 27, 2016.

Aprecia Pharmaceuticals develops and manufactures therapeutically differentiated products for branded, generic, and OTC pharmaceutical and nutraceutical partners. Aprecia's technology achieves a parad…

Articles about Aprecia Pharmaceuticals' Series D Round: